148 related articles for article (PubMed ID: 22893694)
1. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study.
Magliano DJ; Davis WA; Shaw JE; Bruce DG; Davis TM
Eur J Endocrinol; 2012 Oct; 167(4):589-99. PubMed ID: 22893694
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of hospitalization for tendon rupture in type 2 diabetes: the Fremantle diabetes study.
Zakaria MH; Davis WA; Davis TM
Diabet Med; 2014 Apr; 31(4):425-30. PubMed ID: 24151882
[TBL] [Abstract][Full Text] [Related]
3. Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I.
Davis WA; Zilkens RR; Starkstein SE; Davis TM; Bruce DG
Diabetologia; 2017 Jan; 60(1):89-97. PubMed ID: 27717960
[TBL] [Abstract][Full Text] [Related]
4. Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the Fremantle Diabetes Study.
Davis TM; Drinkwater J; Davis WA
Diabet Med; 2014 Aug; 31(8):913-9. PubMed ID: 24661305
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Drinkwater JJ; Davis TME; Turner AW; Bruce DG; Davis WA
Diabetes Care; 2019 Feb; 42(2):288-296. PubMed ID: 30523034
[TBL] [Abstract][Full Text] [Related]
6. Risk of colorectal cancer in type 2 diabetic patients: a population-based cohort study.
Wang JY; Chao TT; Lai CC; Wang CY; Wu VC; Wang SM; Lin HI; Tang SH; Lin HW
Jpn J Clin Oncol; 2013 Mar; 43(3):258-63. PubMed ID: 23288931
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Peters KE; Bruce DG; Davis WA
J Clin Endocrinol Metab; 2012 May; 97(5):1581-8. PubMed ID: 22362822
[TBL] [Abstract][Full Text] [Related]
8. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
Villar E; Chang SH; McDonald SP
Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.
Carstensen B; Read SH; Friis S; Sund R; Keskimäki I; Svensson AM; Ljung R; Wild SH; Kerssens JJ; Harding JL; Magliano DJ; Gudbjörnsdottir S;
Diabetologia; 2016 May; 59(5):980-8. PubMed ID: 26924393
[TBL] [Abstract][Full Text] [Related]
10. Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study.
Hamilton EJ; Martin N; Makepeace A; Sillars BA; Davis WA; Davis TM
PLoS One; 2013; 8(3):e60502. PubMed ID: 23536910
[TBL] [Abstract][Full Text] [Related]
11. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II.
Hart J; Hamilton EJ; Makepeace A; Davis WA; Latkovic E; Lim EM; Dyer JR; Davis TM
J Diabetes Complications; 2015; 29(8):1092-7. PubMed ID: 26243688
[TBL] [Abstract][Full Text] [Related]
14. Detection bias may be the main cause of increased cancer incidence among diabetics: results from the Rotterdam Study.
De Bruijn KM; Ruiter R; de Keyser CE; Hofman A; Stricker BH; van Eijck CH
Eur J Cancer; 2014 Sep; 50(14):2449-55. PubMed ID: 25047425
[TBL] [Abstract][Full Text] [Related]
15. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study.
Deng Z; Gu Y; Hou X; Zhang L; Bao Y; Hu C; Jia W
Diabetes Metab Res Rev; 2016 Mar; 32(3):325-32. PubMed ID: 26409171
[TBL] [Abstract][Full Text] [Related]
16. Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study.
Hamilton E; Davis WA; Bruce DG; Davis TM
J Clin Endocrinol Metab; 2017 Feb; 102(2):551-559. PubMed ID: 27880070
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy.
Ballotari P; Vicentini M; Manicardi V; Gallo M; Chiatamone Ranieri S; Greci M; Giorgi Rossi P
BMC Cancer; 2017 Oct; 17(1):703. PubMed ID: 29070034
[TBL] [Abstract][Full Text] [Related]
18. Dementia complicating type 2 diabetes and the influence of premature mortality: the Fremantle Diabetes Study.
Bruce DG; Davis TME; Davis WA
Acta Diabetol; 2019 Jul; 56(7):767-776. PubMed ID: 30945048
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study.
Hamilton EJ; Davis WA; Siru R; Baba M; Norman PE; Davis TME
Diabetes Care; 2021 Mar; 44(3):722-730. PubMed ID: 33441420
[TBL] [Abstract][Full Text] [Related]
20. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Li CI; Liu CS; Lin WY; Chen CC; Yang SY; Lee CC; Li TC
Endocr Relat Cancer; 2012 Aug; 19(4):473-83. PubMed ID: 22544890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
